Jeffrey Beck, MD
Physical Medicine & Rehabilitation · Terre Haute, INNPI 1063605921
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Medtronic at 58.8% of the total. Reporting peaked in 2019 at $4,572 and has fallen 88.1% since, to $543 in 2025. Among physical medicine & rehabilitation clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $24.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Biodelivery Sciences International, Inc.$1K
- Relievant Medsystems, Inc.$882
- MML US, Inc.$668
- Boston Scientific$462
- Abbott$421
- plus $783 from 19 others
What the payments were for
- Speaking & faculty fees$3,00029%
- Travel & lodging$1,93419%
- Food & beverage$5,36452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 258 | $6,055 |
| Biodelivery Sciences International, Inc. | 37 | $1,027 |
| Relievant Medsystems, Inc. | 9 | $882 |
| MML US, Inc. | 37 | $668 |
| Boston Scientific | 35 | $462 |
| Abbott | 5 | $421 |
| Saluda Medical Americas, Inc. | 11 | $157 |
| Spinal Simplicity, LLC | 6 | $140 |
| Si-bone, Inc. | 3 | $74 |
| Pfizer | 4 | $65 |
| Vertos Medical, Inc. | 3 | $52 |
| Electronic Waveform Lab, Inc. | 1 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| AbbVie(2 entities) | 2 | $29 |
| Averitas Pharma Inc. | 1 | $26 |
| Painteq LLC | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Vertiflex, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Nevro Corp. | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
| SPR Therapeutics, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADAPTIVESTIM$2,000
- Intracept$1,505
- KYPHON Balloon Kyphoplasty$1,432
- BELBUCA$750
- ReActiv8$250
- PROCLAIM$225
- INTELLIS ADAPTIVESTIM$212
- ETERNA$149
How this compares
$10,298 in reported general payments places this provider in the 90th percentile of 140 physical medicine & rehabilitation providers in Indiana.
See all physical medicine & rehabilitation providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hysingla ErHydrocodone Bitartrate | 13 | $20,156 |
| BelbucaBuprenorphine Hcl | 22 | $19,628 |
| Buprenorphine | 46 | $12,141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 408 | $5,844 |
| Xtampza ErOxycodone Myristate | 12 | $5,078 |
| Gabapentin | 174 | $2,039 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 59 | $1,475 |
| Pregabalin | 45 | $896 |
| Cephalexin | 61 | $880 |
| Oxycodone Hcl | 56 | $664 |
| Tizanidine Hcl | 54 | $640 |
| Tramadol Hcl | 100 | $497 |
| Baclofen | 21 | $333 |
| Celecoxib | 20 | $163 |
| Methylprednisolone | 23 | $156 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $31 | $24,70734 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 140 physical medicine & rehabilitation providers in Indiana.
Other physical medicine & rehabilitation in Terre Haute
- Christina WalzFort Wayne$503K
- Shashank DaveIndianapolis$198K
- Sayed WaheziFort Wayne$161K
- Andrew DavissonNew Castle$74K
- Sachin MehtaIndianapolis$60K
- David StenslandFort Wayne$24K
- Scott TaylorNew Castle$18K
- Daniel RothFort Wayne$10K
- Anthony MimmsIndianapolis$10K
- Flora HammondIndianapolis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.